New Owner
Alexion Pharmaceuticals - Taligen Therapeutics
Alexion Pharmaceuticals acquires Taligen Therapeutics
Announced: January 31, 2011
Type: Acquisition
Disposition: Combined
Terms: Cash
Status: Complete
Amount: $ 111,000,000
